COMPARISONS OF ONE-YEAR CLINICAL OUTCOMES OF EVEROLIMUS- VERSUS SIROLIMUS- VERSUS PACLITAXEL-ELUTING STENTS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Target lesion failure (TLF) was defined as the composite of cardiac death, target lesion recurrent nonfatal myocardial infarction (Re-MI), or target lesion revascularization (TLR).

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E46-E46
Main Authors: Chen, Kang-Yin, Rha, Seung-Woon, Li, Yong-Jian, Li, Guang-Ping, Elnagar, Amro, Choi, Byoung Geol, Im, Sung il, Kim, Sunwon, Na, Jin Oh, Han, Seongwoo, Choi, Cheol Ung, Lim, Hong Euy, Kim, Jin Won, Kim, Eung Ju, Seo, Hong-Seog, Park, Chang Gyu, Oh, Dong Joo, Jeong, Myung Ho
Format: Article
Language:English
Subjects:
Cardiology
Clinical outcomes
Confidence intervals
Heart attacks
Stents
Thrombosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Target lesion failure (TLF) was defined as the composite of cardiac death, target lesion recurrent nonfatal myocardial infarction (Re-MI), or target lesion revascularization (TLR).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60047-3